Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss conditions like Telogen Effluvium and Alopecia Areata often feel scalp pain and are more likely to have anxiety, but not necessarily depression.

Lower BDNF levels link to worse depression in alopecia areata patients.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

Hair proteomics could be a useful, non-invasive tool for identifying stress-related disorders.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Combining warning symbols with education significantly reduced medication crushing errors in nursing homes.

Extracellular vesicles can worsen Alzheimer's but also offer potential for diagnosis and treatment.

Brain-made chemicals can control nerve cell function differently in various parts of a mouse's brain, which may help us understand neurological conditions.

Trichotillomania is a hair-pulling disorder needing different treatments than OCD.

Alopecia affects mental health, causing depression and anxiety, but new treatments can improve both hair growth and quality of life.

Woodhouse-Sakati syndrome can cause writer's cramp and other varied symptoms, highlighting the importance of genetic testing for diagnosis.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

Advanced technologies can improve understanding and monitoring of skin-brain interactions.

Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Women with PCOS often have more sleep problems than the general population.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Chronic finasteride use in male rats doesn't strongly cause depression or anxiety due to adaptive stress hormone changes.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

L. plantarum MTCC 1325 may help improve memory and cognitive functions in Alzheimer's.

Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

The letter criticizes generalizations about older patients' abilities and calls for respectful, individualized care, while the original authors defend the need to adapt communication for those with impairments.

People with the same genetic mutation for Woodhouse-Sakati syndrome can have different symptoms.